Colorectal Neoplasms Clinical Trials in Aurora, Colorado

7 studies are recruiting for colorectal neoplasms in Aurora, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. PRE-ISPY Phase I/II Oncology Platform Program

    PRE-ISPY Phase I/II (I-SPY-P1) is an open-label, multisite platform study with multiple ongoing drug regimen arms added by protocol amendment which is designed to evaluate single agents or combinations in locally advanced, incurable, or metastatic solid tumors and/or oligometastatic malignancy and/…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Colorado Cancer Center, Aurora, Colorado
    Locations
    10 in total
    Run by
    QuantumLeap Healthcare Collaborative
  2. A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

    The purpose of this study is to determine the putative recommended phase 2 dose(s) (RP2Ds) and best way to take (optimal route of administration) JNJ-89402638 and to determine the safety of JNJ-89402638 at the RP2D(s) in participants with metastatic colorectal cancer (mCRC) and metastatic gastric c…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Colorado Denver Anschultz Medical Campus, Aurora, Colorado
    Locations
    12 in total
    Run by
    Janssen Research & Development, LLC
  3. A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

    The purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant dies (overall survival), when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovo…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    University of Colorado Denver Anschultz Medical Campus, Aurora, Colorado
    Locations
    251 in total
    Run by
    Janssen Research & Development, LLC
  4. Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

    The purpose of this study is to learn more about a new medicine called PF-08634404, and how well it works in people with cancer of the colon or rectum (CRC)). The goal is to understand if the new study medicine, combined with chemotherapy that is approved for colorectal cancer, can help people whos…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Rocky Mountain Cancer Centers, LLP, Aurora, Colorado
    Locations
    308 in total
    Run by
    Pfizer
  5. Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

    This is a multi-site comparative effectiveness randomized controlled trial (RCT) comparing annual fecal immunochemical testing (FIT) and colonoscopy for post-polypectomy surveillance among adults aged 65-82 with a history of colorectal polyps who are due for surveillance colonoscopy.

    Stage
    Not phased
    Ages
    65 to 82
    Site
    University of Colorado, Aurora, Colorado
    Locations
    24 in total
    Run by
    Dartmouth-Hitchcock Medical Center
  6. A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

    This study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer. This study will also determine what side effects happen when participants take this combination of drugs. A side effect is anythin…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Rocky Mountain Cancer Centers, LLP, Aurora, Colorado
    Locations
    366 in total
    Run by
    Seagen, a wholly owned subsidiary of Pfizer
  7. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

    This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of your blood. Once tumors have grown bigger in one place but haven't spread, they're called locally advanced. If your cancer has spread to other parts …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora, Colorado
    Locations
    48 in total
    Run by
    Seagen, a wholly owned subsidiary of Pfizer

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.